Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
Conditions
- Myeloma
- Transplant-eligible Patients
Interventions
- BIOLOGICAL: Ex-vivo expanded effector cells
Sponsor
Dartmouth-Hitchcock Medical Center
Collaborators